BIOLASE Achieves Sales Milestone With 20,000th Laser Sold

BIOLASE Achieves Sales Milestone With 20,000th Laser Sold Worldwide 
IRVINE, CA -- (Marketwire) -- 09/06/12 --  BIOLASE, Inc. (NASDAQ:
BIOL), the world's leading dental laser manufacturer and distributor,
today announced that it has recently achieved a significant milestone
with the sale of its 20,000th laser system.  
Federico Pignatelli, Chairman and CEO, said, "We are very proud to
have reached such an important sales milestone as we believe that no
other company has sold 20,000 lasers in the medical field. We look
forward to continued growth and market leadership driven by
progressively expanding adoption of our WaterLaseCopyright systems,
which include the iPlus, MDX300 and MDX450, and our newly introduced
EPIC 10(TM) diode laser system, the next evolution of our Total Diode
Solution, once regulatory clearance is received in the U.S. and
About BIOLASE, Inc.
 BIOLASE, Inc., the World's leading Dental Laser
Company, is a medical technology company that develops, manufactures
and markets dental lasers and also distributes and markets dental
imaging equipment; products that are focused on technologies that
advance the practice of dentistry and medicine. The Company's laser
products incorporate approximately 290 patented and patent pending
technologies designed to provide biologically clinically superior
performance with less pain and faster recovery times. Its imaging
products provide cutting-edge technology at competitive prices to
deliver the best results for dentists and patients. BIOLASE's
principal products are dental laser systems that perform a broad
range of dental procedures, including cosmetic and complex surgical
applications, and a full line of dental imaging equipment. BIOLASE
has sold more than 20,100 lasers among 16,000 customers. Other
products under development address ophthalmology and other medical
and consumer markets.  
For updates and information on laser and Waterlase dentistry, find
BIOLASE at, Twitter at, and YouTube at  
This press release may contain forward-looking statements within the
meaning of safe harbor provided by the Securities Reform Act of 1995
that are based on the current expectations and estimates by our
management. These forward-looking statements can be identified
through the use of words such as "anticipates," "expects," "intends,"
"plans," "believes," "seeks," "estimates," "may," "will," and
variations of these words or similar expressions. Forward-looking
statements are based on management's current, preliminary
expectations and are subject to risks, uncertainties and other
factors which may cause the Company's actual results to differ
materially from the statements contained herein, and are described in
the Company's reports it files with the Securities and Exchange
Commission, including its annual and quarterly reports. No undue
reliance should be placed on forward-looking statements. Such
information is subject to change, and we undertake no obligation to
update such statements. 
For further information, please contact: 
Jill Bertotti
Allen & Caron
Press spacebar to pause and continue. Press esc to stop.